Free Trial

IQ-AI (IQAI) Competitors

IQ-AI logo
GBX 1.02
0.00 (0.00%)
(As of 11/1/2024 ET)

IQAI vs. INHC, FDBK, DVRG, TRLS, SENS, EMIS, CRW, INS, KOO, and RENX

Should you be buying IQ-AI stock or one of its competitors? The main competitors of IQ-AI include Induction Healthcare Group (INHC), Feedback (FDBK), DeepVerge (DVRG), Trellus Health (TRLS), Sensyne Health (SENS), EMIS Group (EMIS), Craneware (CRW), Instem (INS), Kooth (KOO), and Renalytix (RENX). These companies are all part of the "health information services" industry.

IQ-AI vs.

IQ-AI (LON:IQAI) and Induction Healthcare Group (LON:INHC) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, profitability, institutional ownership, dividends, risk, earnings, analyst recommendations, valuation and community ranking.

Induction Healthcare Group received 8 more outperform votes than IQ-AI when rated by MarketBeat users. Likewise, 93.33% of users gave Induction Healthcare Group an outperform vote while only 66.67% of users gave IQ-AI an outperform vote.

CompanyUnderperformOutperform
IQ-AIOutperform Votes
6
66.67%
Underperform Votes
3
33.33%
Induction Healthcare GroupOutperform Votes
14
93.33%
Underperform Votes
1
6.67%

In the previous week, Induction Healthcare Group's average media sentiment score of 0.44 beat IQ-AI's score of 0.00 indicating that Induction Healthcare Group is being referred to more favorably in the news media.

Company Overall Sentiment
IQ-AI Neutral
Induction Healthcare Group Neutral

IQ-AI has higher earnings, but lower revenue than Induction Healthcare Group.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
IQ-AI£538.19K4.22N/AN/AN/A
Induction Healthcare Group£13.65M0.57-£3.25M-£0.03-275.00

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
IQ-AI
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
Induction Healthcare Group
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

46.3% of Induction Healthcare Group shares are owned by institutional investors. 66.0% of IQ-AI shares are owned by insiders. Comparatively, 54.6% of Induction Healthcare Group shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

IQ-AI has a beta of 2.25, indicating that its stock price is 125% more volatile than the S&P 500. Comparatively, Induction Healthcare Group has a beta of -0.41, indicating that its stock price is 141% less volatile than the S&P 500.

Induction Healthcare Group has a net margin of -23.86% compared to IQ-AI's net margin of -77.52%. Induction Healthcare Group's return on equity of -14.53% beat IQ-AI's return on equity.

Company Net Margins Return on Equity Return on Assets
IQ-AI-77.52% -140.75% -22.03%
Induction Healthcare Group -23.86%-14.53%-7.32%

Summary

Induction Healthcare Group beats IQ-AI on 8 of the 12 factors compared between the two stocks.

Get IQ-AI News Delivered to You Automatically

Sign up to receive the latest news and ratings for IQAI and its competitors with MarketBeat's FREE daily newsletter.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

IQAI vs. The Competition

MetricIQ-AIHealth Information Services IndustryMedical SectorLON Exchange
Market Cap£2.27M£218.32M£5.40B£1.59B
Dividend Yield17.30%6.58%5.13%11.05%
P/E Ratio-13.67652.83113.461,740.37
Price / Sales4.22338.721,484.40230,520.65
Price / Cash10.2543.5739.6435.87
Price / BookN/A4.924.652.88
Net IncomeN/A-£5.00M£119.06M£144.83M
7 Day PerformanceN/A0.53%0.79%0.11%
1 Month Performance-7.66%-1.12%5.65%-0.11%
1 Year Performance-73.72%10.97%36.76%15.28%

IQ-AI Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
IQAI
IQ-AI
N/AGBX 1.03
flat
N/A-75.6%£2.27M£538,190.00-13.676Gap Up
INHC
Induction Healthcare Group
N/AGBX 8.34
-1.9%
N/A-67.3%£7.82M£13.65M-277.8374Gap Down
FDBK
Feedback
N/AGBX 44.85
+3.1%
N/A-42.1%£5.98M£1.02M-172.5024Gap Up
High Trading Volume
DVRG
DeepVerge
N/AGBX 0.15
flat
N/AN/A£1.14M£12.41M-15.0073
TRLS
Trellus Health
N/AGBX 0.65
-3.7%
N/A-87.1%£1.05M£35,000.00-21.6731Gap Down
SENS
Sensyne Health
N/AGBX 0.35
-33.3%
N/A+0.0%£583,000.00£7.81M-0.0270Gap Down
EMIS
EMIS Group
N/AGBX 1,920
flat
N/A+0.0%£1.23B£176.86M4,085.111,560
CRW
Craneware
2.3159 of 5 stars
GBX 1,995
+0.8%
GBX 2,700
+35.3%
+23.7%£705.03M£189.27M7,673.08734High Trading Volume
INS
Instem
N/AGBX 830
flat
N/A+8.5%£199.62M£61.63M5,928.57500
KOO
Kooth
3.0039 of 5 stars
GBX 174
-1.1%
GBX 585
+236.2%
-43.0%£63.48M£54.17M1,450.00478Insider Buying
High Trading Volume
RENX
Renalytix
N/AGBX 7.55
-5.6%
N/A-81.8%£12.53M£2.29M-31.46102Gap Up

Related Companies and Tools


This page (LON:IQAI) was last updated on 11/2/2024 by MarketBeat.com Staff
From Our Partners